UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Replicating and non-replicating viral vectors for vaccine development

Current opinion in biotechnology, 2007-12, Vol.18 (6), p.546-556

Robert-Guroff, Marjorie

2007

Volltextzugriff (PDF)

Accelerating HIV vaccine development using non-human primate models

Expert review of vaccines, 2019-01, Vol.18 (1), p.61-73

2019

Volltextzugriff (PDF)

Multiple Vaccine-Elicited Nonneutralizing Antienvelope Antibody Activities Contribute to Protective Efficacy by Reducing both Acute and Chronic Viremia following Simian/Human Immunodeficiency Virus SHIV89.6P Challenge in Rhesus Macaques

Journal of Virology, 2010-07, Vol.84 (14), p.7161-7173

2010

Volltextzugriff (PDF)

Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251

Nature communications, 2023-03, Vol.14 (1), p.1264-1264, Article 1264

2023

Volltextzugriff (PDF)

Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1

Frontiers in immunology, 2019-05, Vol.10, p.1025-1025

2019

Volltextzugriff (PDF)

Challenges in mucosal HIV vaccine development: lessons from non-human primate models

Viruses, 2014-08, Vol.6 (8), p.3129-3158

2014

Volltextzugriff (PDF)

The Yin and Yang of ADCC-Mediating Antibodies

EBioMedicine, 2016-01, Vol.3 (C), p.10-11

Robert-Guroff, Marjorie

2016

Volltextzugriff (PDF)

Disruption of NBS1/MRN Complex Formation by E4orf3 Supports NF-κB That Licenses E1B55K-Deleted Adenovirus-Infected Cells to Accumulate DNA>4n

Microbiology spectrum, 2022-02, Vol.10 (1), p.e0188121-e0188121

2022

Volltextzugriff (PDF)

Beyond Oncolytics: E1B55K-Deleted Adenovirus as a Vaccine Delivery Vector

PloS one, 2016-07, Vol.11 (7), p.e0158505-e0158505

2016

Volltextzugriff (PDF)

A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity

Journal of immunological methods, 2006-01, Vol.308 (1), p.53-67

2006

Volltextzugriff (PDF)

The use of nonhuman primate models in HIV vaccine development

PLoS medicine, 2008-08, Vol.5 (8), p.e173-e173

2008

Volltextzugriff (PDF)

Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention

Current HIV research, 2013-07, Vol.11 (5), p.407-420

2013

Volltextzugriff (PDF)

High-throughput profiling of anti-glycan humoral responses to SIV vaccination and challenge

PloS one, 2013-09, Vol.8 (9), p.e75302-e75302

2013

Volltextzugriff (PDF)

Impact of Viral Dose and Major Histocompatibility Complex Class IB Haplotype on Viral Outcome in Mauritian Cynomolgus Monkeys Vaccinated with Tat upon Challenge with Simian/Human Immunodeficiency Virus SHIV89.6P

Journal of Virology, 2010-09, Vol.84 (17), p.8953-8958

2010

Volltextzugriff (PDF)

DNA Vaccines Expressing Different Forms of Simian Immunodeficiency Virus Antigens Decrease Viremia upon SIVmac251 Challenge

Journal of Virology, 2005-07, Vol.79 (13), p.8480-8492

2005

Volltextzugriff (PDF)

Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques

Vaccine, 2011-12, Vol.30 (1), p.78-94

2011

Volltextzugriff (PDF)

Live recombinant vectors for AIDS vaccine development

Current molecular medicine, 2003-05, Vol.3 (3), p.273-284

2003

Volltextzugriff (PDF)

Mucosal and Systemic γδ+ T Cells Associated with Control of Simian Immunodeficiency Virus Infection

The Journal of immunology (1950), 2016-12, Vol.197 (12), p.4686-4695

2016

Volltextzugriff (PDF)

New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design

Expert review of vaccines, 2016-08, Vol.15 (8), p.1015-1027

2016

Volltextzugriff (PDF)

Monoclonal Antibodies Specific for the V2, V3, CD4-Binding Site, and gp41 of HIV-1 Mediate Phagocytosis in a Dose-Dependent Manner

Journal of virology, 2017-04, Vol.91 (8)

2017

Volltextzugriff (PDF)

Vaccine Protection against a Heterologous, Non-Syncytium-Inducing, Primary Human Immunodeficiency Virus

Journal of Virology, 1998-12, Vol.72 (12), p.10275-10280

1998

Volltextzugriff (PDF)

Mucosal Immunity and Protection Against HIV/SIV Infection: Strategies and Challenges for Vaccine Design

International reviews of immunology, 2009-01, Vol.28 (1-2), p.20-48

2009

Volltextzugriff (PDF)

Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model

Clinical immunology (Orlando, Fla.), 2014-08, Vol.153 (2), p.264-276

2014

Volltextzugriff (PDF)

Factors Associated with Slow Disease Progression in Macaques Immunized with an Adenovirus-Simian Immunodeficiency Virus (SIV) Envelope Priming-gp120 Boosting Regimen and Challenged Vaginally with SIVmac251

Journal of Virology, 1999-09, Vol.73 (9), p.7430-7440

1999

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(119)

Sprache

Englisch
(119)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(95)
Life Sciences & Biomedicine
(84)
Animals
(63)
Aids/hiv
(57)
Biological And Medical Sciences
(45)
Virology
(42)
Female
(35)
Male
(33)
Antibodies, Viral - Analysis
(32)
Immunology
(28)
Macaca Mulatta
(26)
Human Immunodeficiency Virus
(24)
Medical Sciences
(24)
Aids Vaccines - Immunology
(23)
Fundamental And Applied Biological Sciences. Psychology
(23)
Adult
(21)
Hiv-1 - Immunology
(21)
Molecular Sequence Data
(21)
Simian Immunodeficiency Virus - Immunology
(21)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Replicating and non-replicating viral vectors for vaccine development

Accelerating HIV vaccine development using non-human primate models

Multiple Vaccine-Elicited Nonneutralizing Antienvelope Antibody Activities Contribute to Protective Efficacy by Reducing both Acute and Chronic Viremia following Simian/Human Immunodeficiency Virus SHIV89.6P Challenge in Rhesus Macaques

Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251

Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1

Challenges in mucosal HIV vaccine development: lessons from non-human primate models

The Yin and Yang of ADCC-Mediating Antibodies

Disruption of NBS1/MRN Complex Formation by E4orf3 Supports NF-κB That Licenses E1B55K-Deleted Adenovirus-Infected Cells to Accumulate DNA>4n

Low-Dose Penile SIVmac251 Exposure of Rhesus Macaques Infected with Adenovirus Type 5 (Ad5) and Then Immunized with a Replication-Defective Ad5-Based SIV gag/pol/nef Vaccine Recapitulates the Results of the Phase IIb Step Trial of a Similar HIV-1 Vaccine

Beyond Oncolytics: E1B55K-Deleted Adenovirus as a Vaccine Delivery Vector

A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity

The use of nonhuman primate models in HIV vaccine development

Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention

High-throughput profiling of anti-glycan humoral responses to SIV vaccination and challenge

Impact of Viral Dose and Major Histocompatibility Complex Class IB Haplotype on Viral Outcome in Mauritian Cynomolgus Monkeys Vaccinated with Tat upon Challenge with Simian/Human Immunodeficiency Virus SHIV89.6P

DNA Vaccines Expressing Different Forms of Simian Immunodeficiency Virus Antigens Decrease Viremia upon SIVmac251 Challenge

Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques

Live recombinant vectors for AIDS vaccine development

Mucosal and Systemic γδ+ T Cells Associated with Control of Simian Immunodeficiency Virus Infection

New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design

Monoclonal Antibodies Specific for the V2, V3, CD4-Binding Site, and gp41 of HIV-1 Mediate Phagocytosis in a Dose-Dependent Manner

Vaccine Protection against a Heterologous, Non-Syncytium-Inducing, Primary Human Immunodeficiency Virus

Mucosal Immunity and Protection Against HIV/SIV Infection: Strategies and Challenges for Vaccine Design

Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model

Factors Associated with Slow Disease Progression in Macaques Immunized with an Adenovirus-Simian Immunodeficiency Virus (SIV) Envelope Priming-gp120 Boosting Regimen and Challenged Vaginally with SIVmac251

Aktive Filter

Suchergebnisse filtern